New Venturetec Ltd. published the Agenda to the Extraordinary Shareholders' Meeting of July 10, 2019.


Zug, June 14, 2019. The agenda and invitation to the Extraordinary Shareholders' Meeting of New Venturetec Ltd., which will be held at 09:30, 10 July 2019 at the Parkhotel Zug, Industriestrasse 14, in Zug, Switzerland, is published and available at

The Board recommends to vote against all proposals put forward by a group of minority shareholders, to the extent they can validly be submitted to a shareholder vote.

The Company will continue to invest in venture companies and increasingly as private equity in more mature businesses, as co-investments with established firms. Co-investments with Board members will be excluded.

Further, New Venturetec published today the audited interim statutory financial statements as at April 30, 2019, prepared in accordance with SWISS GAAP. These financial statements are available on


About New Venturetec Ltd.

New Venturetec Ltd. is a publicly traded Swiss investment company (SIX: NEV) which holds participations in venture companies in the areas of biotechnology and technology which are domiciled in the USA.

The investment horizon should be 10 years or more. A shareholder is recommended to follow the development with interest and base an investment or disinvestment decision on results of the development of the portfolio companies rather than on the general capital market and the investors’ sentiment. Any investor should only invest in New Venturetec Ltd. if he can afford the complete loss of the investment without having to change his lifestyle. Significant risk is involved and the timelines may exceed the expectations. In addition, the market of New Venturetec Ltd. shares is very illiquid. The risks of venture investments are 100%. The total loss of the investment has to be considered as a realistic possibility.